Owing to the increasing awareness regarding the risks of tobacco use, several tobacco companies have come up with tobacco products that are classified as “modified risk” products. According to the latest release by Institute of Medicine, the Food and Safety Administration has to put in more research before allowing the release of these products in Read more
Archive : FDA
Drug Does Not Stall Memory Loss during Early Onset of Alzheimer’s
Mematime is an approved drug for Alzheimer’s patients According to a new study, Mematime will not assist patients to reduce the loss of memory and other cognitive functions during the early onset of Alzheimer’s disease. The drug has been approved by the United States Food and Drug Administration authorities for using in patients who are Read more
Blood Thinner Approved By FDA
FDA approves blood thinner Brilinta After a long wait, the Foods and Drugs Administration authorities have given an approval to a new blood thinning medication, Brilinta. This medicine will be beneficial to patients diagnosed with severe cardiac symptoms. Brilinta will reduce the possibility of a heart attack that may cause death in such patients. Acute Read more
Use Sunscreen To Down The Risk Of Skin Cancer
Before an outing under a sunny day, be sure that you have packed the sunscreen up. As the summer approach, it’s important to be well aware of the chances of skin cancer due to the UV rays, the sun emits. Form a recent survey it has been reported that the 40 percent of the patients, Read more
Breast Cancer Patients Await Approval of Avastin
Patients suffering from breast cancer have been making a case for the Foods and Drugs Administration to approve Avastin as a prescribed medication for treating the illness. These presentations were made on the first day of the two-day hearing under progress. Genetech, which manufactures Avastin, is working to convince the FDA to reverse its December Read more
FDA Recommends Reduced Dosage of ESAs For Chronic Kidney Disease Treatments
The Food and Drug Administration (FDA) recommended lower dosage to check the cardiovascular events related to Erythropoiesis-Stimulating Agents (ESAs) which are used in anemia treatment for patients with chronic kidney diseases. Stroke, thrombosis and even death are the cardiovascular effects related to the dosing.
Remarkable Role of Drug Telaprevir in Hepatitis C Treatment
Hepatitis C, the most common form of hepatitis which affects almost 170-180 million people world wide caused by the infectous agent HCV (hepatitis C Virus) finds hope in the drug Telaprevir said a team of researchers led by Dr. Ira M. Jacobson (Newyork Presbyterian Hospital).The U.S. FDA gave approval to telaprevir to be used on Read more
FDA Plans to Monitor Foods and Drugs Imports
New FDA policy to monitor imports The commissioner of the Foods and Drugs Administration, Dr. Margaret Hamburg has spoken about the overwhelming amount of imports of foods and drugs within the country. She has now proposed a new policy to enabler the FDA to regulate the inflow of imported foods and drugs. The new framework Read more
Cigarette Packs to comes with Warning Labels – Corpse, Rotting Teeth
Images like corpse as well as cancerous lungs and including other nine graphics warning will be added with the cigarette packets in the U.S from the next year, which the tobacco companies already start placing. In this respect Food and Drug Administration said “The labels need to be placed under a 2 year old tobacco Read more
FDA Approval For New Drug Treating Hospital Scourge
The Event That Lead To The Research In 1971, Dr. Sherwood L. Gorbach who was a researcher in infectious diseases received an emergency call for assistance from a drug company. The company’s antibiotic medicine that had been administered to some patients in a hospital in New Zealand had developed complications. Many of the patients treated Read more